Effects of hyperbaric oxygen on expression of... (2001 study) Skip to main content
Study Scand J Clin Lab Invest 2001

Effects of hyperbaric oxygen on expression of fibrinolytic factors of human endothelium in a simulated ischaemia/reperfusion situation

Tjärnström J, Holmdahl L, Falk P, Falkenberg M, Arnell P, Risberg B, Scand J Clin Lab Invest, 2001

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Scientists exposed human blood vessel cells grown in a lab to a low-oxygen period, then treated them with hyperbaric oxygen to see how the cells responded.

What They Found

This laboratory cell study found that hyperbaric oxygen treatment after a period of oxygen deprivation significantly increased levels of three clot-related proteins (t-PA, PAI-1, and uPA) compared to cells treated with normal-pressure air or untreated control cells. The increase was measured immediately after 1.5 hours of hyperbaric oxygen reoxygenation. The researchers concluded that in this model, hyperbaric oxygen stimulates the release of these fibrinolytic (clot-breakdown-related) factors.

What This Means for Canadian Patients

This was a laboratory study using cultured cells, not a study of patients, so it does not show how hyperbaric oxygen affects people directly. The abstract suggests these findings might be relevant to trauma care in preventing blood clots or microembolization, but this remains a proposed area for further study rather than a demonstrated patient benefit.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This was a small laboratory experiment using cultured cells in a simulated model, not living patients, so the results may not reflect what happens in the human body during actual injury or treatment.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Study
Category Decompression Sickness
Source Pubmed
PubMed ID 11763412
Year Published 2001
Journal Scand J Clin Lab Invest
MeSH Terms Cells, Cultured; Endothelium, Vascular; Fibrinolysis; Humans; Hyperbaric Oxygenation; Plasminogen Activator Inhibitor 1; Reperfusion Injury; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator

Cite This Study

Share

This study relates to Decompression Sickness. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Decompression Sickness

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 16, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology